Guest guest Posted August 17, 2004 Report Share Posted August 17, 2004 I wanted to let you know about an important drug demonstration program that would cover thousands of dollars in medicine costs for qualified participants. If you or someone you know qualifies to participate, we urge you to take advantage of this opportunity. Just a few weeks ago, the U.S. Department of Health and Human Services announced plans for the Medicare Replacement Drug Demonstration, a program that will provide breast cancer patients access to several important oral anti-cancer drugs that were not previously covered by Medicare. Click here to visit Centers for Medicare and Medicaid Services for additional information. It is estimated that demonstration participants will save up to 90 percent, in some cases thousands of dollars, off the retail cost of these life-enhancing medicines, depending on the specific medicine and the beneficiary's income level. Slots to participate in this drug demonstration program are still available and qualified Medicare beneficiaries without drug coverage are encouraged to apply. The drugs included in the project are tamoxifen (Nolvadex®), letrozole (Femara®), exemestane (Aromasin®), anastrozole (Arimidex®), and toremifene (Fareston®). Last week, the HHS announced the addition of two new drugs to the list of drugs covered under the demonstration program including Mesnex tablets. Mesnex tablets are used to prevent some side effects in patients undergoing certain kinds of chemotherapy and are a replacement for intravenous Mesnex. Information about the program, including the complete list of covered drugs, brochures, and application forms, may be downloaded from the Centers for Medicare and Medicaid Services (CMS) Web site participating in the program. Please pass this information along to anyone you think might be interested in Thank you. Diane L. Balma Director of Public Policy The G. Komen Breast Cancer Foundation Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 18, 2004 Report Share Posted August 18, 2004 Great info Doris! It's about time they gave us some help with these drugs. I'm very lucky to have great insurance. But I know there are so many who don't. Hallelujah! In breastcancer2 , " Doris " <mkayla38@y...> wrote: > I wanted to let you know about an important drug demonstration program > that would cover thousands of dollars in medicine costs for qualified > participants. If you or someone you know qualifies to participate, we > urge you to take advantage of this opportunity. > > Just a few weeks ago, the U.S. Department of Health and Human Services > announced plans for the Medicare Replacement Drug Demonstration, a > program that will provide breast cancer patients access to several > important oral anti-cancer drugs that were not previously covered by > Medicare. > > Click here to visit Centers for Medicare and Medicaid Services for > additional information. > > It is estimated that demonstration participants will save up to 90 > percent, in some cases thousands of dollars, off the retail cost of > these life-enhancing medicines, depending on the specific medicine and > the beneficiary's income level. Slots to participate in this drug > demonstration program are still available and qualified Medicare > beneficiaries without drug coverage are encouraged to apply. > > The drugs included in the project are tamoxifen (Nolvadex®), letrozole > (Femara®), exemestane (Aromasin®), anastrozole (Arimidex®), and > toremifene (Fareston®). Last week, the HHS announced the addition of > two new drugs to the list of drugs covered under the demonstration > program including Mesnex tablets. Mesnex tablets are used to prevent > some side effects in patients undergoing certain kinds of chemotherapy > and are a replacement for intravenous Mesnex. > > Information about the program, including the complete list of covered > drugs, brochures, and application forms, may be downloaded from the > Centers for Medicare and Medicaid Services (CMS) Web site > participating in the program. > > Please pass this information along to anyone you think might be > interested in > > Thank you. > > Diane L. Balma > Director of Public Policy > The G. Komen Breast Cancer Foundation Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 18, 2004 Report Share Posted August 18, 2004 Great info Doris! It's about time they gave us some help with these drugs. I'm very lucky to have great insurance. But I know there are so many who don't. Hallelujah! In breastcancer2 , " Doris " <mkayla38@y...> wrote: > I wanted to let you know about an important drug demonstration program > that would cover thousands of dollars in medicine costs for qualified > participants. If you or someone you know qualifies to participate, we > urge you to take advantage of this opportunity. > > Just a few weeks ago, the U.S. Department of Health and Human Services > announced plans for the Medicare Replacement Drug Demonstration, a > program that will provide breast cancer patients access to several > important oral anti-cancer drugs that were not previously covered by > Medicare. > > Click here to visit Centers for Medicare and Medicaid Services for > additional information. > > It is estimated that demonstration participants will save up to 90 > percent, in some cases thousands of dollars, off the retail cost of > these life-enhancing medicines, depending on the specific medicine and > the beneficiary's income level. Slots to participate in this drug > demonstration program are still available and qualified Medicare > beneficiaries without drug coverage are encouraged to apply. > > The drugs included in the project are tamoxifen (Nolvadex®), letrozole > (Femara®), exemestane (Aromasin®), anastrozole (Arimidex®), and > toremifene (Fareston®). Last week, the HHS announced the addition of > two new drugs to the list of drugs covered under the demonstration > program including Mesnex tablets. Mesnex tablets are used to prevent > some side effects in patients undergoing certain kinds of chemotherapy > and are a replacement for intravenous Mesnex. > > Information about the program, including the complete list of covered > drugs, brochures, and application forms, may be downloaded from the > Centers for Medicare and Medicaid Services (CMS) Web site > participating in the program. > > Please pass this information along to anyone you think might be > interested in > > Thank you. > > Diane L. Balma > Director of Public Policy > The G. Komen Breast Cancer Foundation Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 18, 2004 Report Share Posted August 18, 2004 Great info Doris! It's about time they gave us some help with these drugs. I'm very lucky to have great insurance. But I know there are so many who don't. Hallelujah! In breastcancer2 , " Doris " <mkayla38@y...> wrote: > I wanted to let you know about an important drug demonstration program > that would cover thousands of dollars in medicine costs for qualified > participants. If you or someone you know qualifies to participate, we > urge you to take advantage of this opportunity. > > Just a few weeks ago, the U.S. Department of Health and Human Services > announced plans for the Medicare Replacement Drug Demonstration, a > program that will provide breast cancer patients access to several > important oral anti-cancer drugs that were not previously covered by > Medicare. > > Click here to visit Centers for Medicare and Medicaid Services for > additional information. > > It is estimated that demonstration participants will save up to 90 > percent, in some cases thousands of dollars, off the retail cost of > these life-enhancing medicines, depending on the specific medicine and > the beneficiary's income level. Slots to participate in this drug > demonstration program are still available and qualified Medicare > beneficiaries without drug coverage are encouraged to apply. > > The drugs included in the project are tamoxifen (Nolvadex®), letrozole > (Femara®), exemestane (Aromasin®), anastrozole (Arimidex®), and > toremifene (Fareston®). Last week, the HHS announced the addition of > two new drugs to the list of drugs covered under the demonstration > program including Mesnex tablets. Mesnex tablets are used to prevent > some side effects in patients undergoing certain kinds of chemotherapy > and are a replacement for intravenous Mesnex. > > Information about the program, including the complete list of covered > drugs, brochures, and application forms, may be downloaded from the > Centers for Medicare and Medicaid Services (CMS) Web site > participating in the program. > > Please pass this information along to anyone you think might be > interested in > > Thank you. > > Diane L. Balma > Director of Public Policy > The G. Komen Breast Cancer Foundation Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.